ArticleNature communications2026
TRNAU1AP and PRPF39 establish integrated control over processing of most abundant human non-coding RNAs.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Although abundance of the metastasis-associated long non-coding RNA MALAT1 depends on the maturation of its triple-helix-containing 3' end via non-canonical processing, the control of this step has remained unknown. Using iterative genome-wide screening, we identified TRNAU1AP and PRPF39 that together control the 3'-end processing of MALAT1, enabling a reduction in its levels. We further show that these factors form part of a previously unrecognized RNase MRP and P control (RMPPc) pathway that, in addition to MALAT1, establishes integrated control over the processing of MEN-β, internal transcribed spacers in pre-rRNA, and 5'-leader sequences in pre-tRNA, thereby impacting fundamental processes prerequisite for translation. We demonstrate that this far-reaching impact is achieved through a single control point: inclusion of the initiating ATG-containing exon 2 in RPP14, an essential component of both RNase MRP and RNase P, thereby controlling both catalytic RNAs-MRP RNA and H1 RNA. Finally, we show that upstream of this primary control point, the RMPPc pathway forms a remarkably interlinked four-pronged feedback circuit that confers stability on post-transcriptional processing of over 90% of the total RNA content in human cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.